Parabilis Medicines, Inc. Common Stock (PBLS)

Health Care·equity

$27.48

-2.17% today

Extended hours $27.88

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

39/ 100

Score level

Below average

5 of 6 checks had data

Business numbers score is on the low side; smart-money score is above the middle, how it compares with the broader market is one of its lowest-scoring factors.

PBLS scores higher than 48% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, Parabilis Medicines, Inc. Common Stock (PBLS) scores 39 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated 9 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 1.05× 30-day average
52-week range: —
Market cap: $5.16B
Earnings date: —

Volume: 1,086,609
Avg. volume (30d): 1,032,798

Open: 28.15
Previous close: 28.09
Day's range (regular session): 27.21 – 29.50

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: -1.08
P/E (TTM): —
EPS (TTM): -2.04

Score breakdown · six named factors

Price trend

—

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for PBLS

6 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for PBLS. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about PBLS right now

Parabilis Medicines, Inc. Common Stock (PBLS) currently scores 39/100 on the Market Census six-factor composite, at the Below average score level. PBLS is -2.17% on the day and -9.97% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of PBLS's data reads poorly than well. The level is a "look before you act" flag. It is not advice. PBLS's strongest factor is insider trades at 90/100 — a very strong read on insider buying and selling. Insider filings currently lean toward buying on this name — a plain read of public filings, not a signal to follow. The weakest factor is company finances at 0/100 — well below average company numbers. A low company-finances reading is the canonical "value trap" warning: technical setups on broken fundamentals don't tend to compound.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See PBLS in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score